Ophthalmology · Brooklyn, NY
NPI
1972689966
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
757 55th Street
Brooklyn, NY, 11220
Phone (718) 437-9282
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
579 services
Medicare patients, 2024
134
Average age 78
Drug cost, 2024
$4.9M
16,963 prescriptions
Company payments, 2025
$18.1
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathy K Man-Wong was code 92012 (ophthalmological e&m), 186 times for 111 patients. In total Kathy K Man-Wong billed 579 services in 18 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 186 | 111 | $70.59 | $13K |
| 92014 Ophthalmological E&M | Office | 96 | 90 | $90.91 | $8,727 |
| 92083 Vision, Hearing, and Speech Services | Office | 76 | 62 | $51.28 | $3,897 |
| 92133 Computerized Ophthalmic Imaging | Office | 70 | 69 | $27.03 | $1,892 |
| 67820 Eye | Office | 38 | 25 | $17.41 | $661 |
| 92020 Ophthalmological E&M | Office | 32 | 31 | $21.45 | $687 |
| 92134 Computerized Ophthalmic Imaging | Office | 19 | 17 | $31.40 | $597 |
| 92250 Angiography | Office | 17 | 17 | $30.75 | $523 |
By year: 2022 $52K for 708 services; 2023 $39K for 624 services; 2024 $39K for 579 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathy K Man-Wong prescribed most often to Medicare patients was Restasis (Cyclosporine), with 2,653 prescriptions and refills. In total Kathy K Man-Wong wrote 16,963 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 2,653 | 3,080 | 371 | $1.9M |
| Vyzulta Latanoprostene Bunod | 2,055 | 2,183 | 221 | $523K |
| Latanoprost Generic | 2,052 | 2,367 | 261 | $11K |
| Timolol Maleate Generic | 1,048 | 1,413 | 157 | $42K |
| Rhopressa Netarsudil Mesylate | 1,047 | 1,339 | 143 | $339K |
| Bepotastine Besilate Generic | 1,030 | 1,066 | 249 | $115K |
| Alphagan P Brimonidine Tartrate | 765 | 879 | 119 | $154K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 697 | 1,224 | 118 | $8,843 |
| Tyrvaya Varenicline Tartrate | 585 | 600 | 85 | $388K |
| Xiidra Lifitegrast | 577 | 665 | 75 | $454K |
| Brinzolamide Generic | 462 | 796 | 92 | $69K |
| Zerviate Cetirizine Hcl | 351 | 358 | 119 | $141K |
| Brimonidine Tartrate Generic | 342 | 414 | 60 | $22K |
| Combigan Brimonidine Tartrate/Timolol | 320 | 385 | 43 | $78K |
| Azelastine Hcl Generic | 316 | 319 | 114 | $2,668 |
Brand drugs: 11,335 claims; generic drugs: 5,628 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathy K Man-Wong $18.1 ($18.1 in general payments such as food, travel and fees) from 1 company. The largest payer was Bausch & Lomb Americas Inc. with $18.1.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 1 | $18.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.